male infertility with idiopathic oligoastenospermia. Male infertility
Conditions
Interventions
Intervention 1: Intervention group: one capsule of Familact available in Iranian Pharmaceutical Market, orally. Intervention 2: Control group: one capsule contain of clomiphene available in Iranian Ph
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: sperm concentration in semen <15000000 per cc Percentage of progressive motile spermatozoa < 32% Total motility <40% Total ejaculated spermatozoa<39*106 Normal level of FSH, LH, Prolactin, and free testosterone in serum
Exclusion criteria
Exclusion criteria: Smoking or alcoholic consumption White blood cells in semen >10 6 Chances of being treated with gonadotropins, anabolic steroids, cancer chemotherapy, NSAIDs Have been treated with infertility medications since two months ago Unwillingness to cooperate during treatment A medical history of chemotherapy or radiotherapy for cancer management A history of X ray radiation exposure since 8 months ago Y chromosome microdeletion Karyotype alterations Testicular atrophy and lack of testicular descending Other secondary causes of infertility History of liver dysfunction and sensitivity to clomiphene Medical history of infertility therapy since 2 months ago Ejaculated volume <1.5 ml Percentage of typical forms<4% abnormal level of FSH, LH, prolactin and free testosterone in serum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sperm concentration in semen. Timepoint: end of study. Method of measurement: Sperm count in semen is calculated using sperm concentration. Sperm concentration refers to the number of sperm per unit volume of semen. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdollah Razi
Bojnourd University of Medical Sciences
Outcome results
None listed